What is the current market size?

The global Vaccines for Livestock Farming market size was valued at USD 1.6 billion in 2023, driven by rising demand for animal-derived food and biosecurity measures.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.8% from 2024 to 2032, with demand rising due to livestock health management and zoonotic disease prevention.

What are the key drivers?

Key drivers include increased livestock production, government funding for disease control, and consumer demand for safe animal products.

What challenges exist in the market?

High R&D costs, regulatory hurdles, and vaccine resistance hinder market growth, requiring innovation to maintain efficacy.

Which regions lead the market?

North America and Europe dominate due to advanced veterinary infrastructure, while Asia-Pacific shows rapid growth from expanding livestock farming.

Who are the top companies?

Key players include Zoetis, Merck Animal Health, Boehringer Ingelheim, and Elanco, leveraging R&D and partnerships to expand market share.

What are future opportunities?

Opportunities lie in emerging markets, personalized vaccines for specific livestock breeds, and sustainable vaccine development.

How does technology impact the market?

Advances like mRNA vaccines, digital monitoring, and AI-driven disease prediction enhance precision and efficiency in livestock health management.

What is the regulatory landscape?

Regulatory bodies like USDA and EMA enforce stringent approval processes, ensuring vaccine safety and quality while encouraging innovation.

Vaccines for Livestock Farming Growth Opportunities & Strategic Forecast 2033

Vaccines for Livestock Farming by Application (Pig, Cattle, Sheep, Chicken and Duck, Other), by Types (Live Attenuated Vaccines, Inactivated Vaccines, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 162

Forecast Period: 2026 - 2033

Market Size: $4812 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 162

Forecast Period: 2026 - 2033

Market Size: $4812 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Vaccines for Livestock Farming Market Overview

The Vaccines for Livestock Farming market encompasses products designed to prevent infectious diseases in domesticated animals, ensuring food security and livestock productivity. As a critical component of agricultural biosecurity, this market supports animal health and sustainable farming. The global Vaccines for Livestock Farming market size reached $8.5 billion in 2025, reflecting robust demand driven by intensifying zoonotic disease risks, regulatory mandates for farm animal health, and advancements in vaccine technology. Market growth outlook remains bullish, with a projected compound annual growth rate (CAGR) of 8.2% from 2026 to 2033, fueled by expanding livestock operations in emerging economies and innovation in mRNA and subunit vaccines.

Loading chart…

Key forces shaping the Vaccines for Livestock Farming industry include technological innovation in vaccine development (e.g., recombinant DNA and adjuvant technologies) and regulatory tailwinds prioritizing food safety. North America remains the largest regional market due to high adoption of preventive veterinary care, while Asia-Pacific is the fastest-growing region, propelled by expanding poultry and swine sectors in China and India. Competitive intensity is rising as biotech firms and agritech startups collaborate to address antimicrobial resistance and improve vaccine delivery systems for smallholder farmers. Strategic mergers and portfolio diversification are becoming pivotal to capture market share in this high-growth arena.

Report Overview

Report Attribute	Details
Market size value in 2025	4.81 billion
Revenue forecast in 2033	8.39 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Zoetis; Boehringer Ingelheim; Ceva; CAHIC; HVRI; Ringpu Biology; Yebio; DHN; WINSUN; Elanco; Virbac; Jinyu Bio-Technology; Chengdu Tecbond; CAVAC; Kyoto Biken Laboratories; FATRO; Vaksindo; Bio-Labs; Avimex Animal Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for animal protein – Surging global population and urbanization are driving increased consumption of meat, dairy, and eggs, necessitating Vaccines for Livestock Farming market expansion to ensure herd health and productivity in intensive farming systems.

Government initiatives and regulatory frameworks – Stringent animal health regulations and subsidies for livestock vaccination programs, particularly in emerging markets, are accelerating market adoption to mitigate zoonotic disease outbreaks and ensure food security.

Restraints2 items

High R&D costs – Development of advanced vaccines (e.g., mRNA, gene-edited) requires significant capital investment, limiting market participation by smaller players and delaying product pipelines.

Fragmented veterinary infrastructure – Inadequate cold chain logistics and veterinary workforce shortages in low- and middle-income countries hinder vaccine distribution and adoption.

Opportunities2 items

Innovation in one-health approaches – Synergies between human and animal health are spurring cross-sectoral R&D partnerships, unlocking novel vaccines with dual applications and expanding the Vaccines for Livestock Farming market size.

Digitalization of farm management – Integration of precision livestock farming technologies (e.g., IoT, AI-driven health monitoring) is creating demand for data-driven vaccination scheduling and targeted immunization protocols.

Challenges2 items

Regulatory variability – Divergent approval processes across regions increase time-to-market complexity, particularly for multinational producers targeting emerging markets.

Farmer cost sensitivity – Price volatility in agricultural commodities and low profit margins deter small-scale farmers from prioritizing prophylactic vaccines over reactive treatments, constraining growth forecast optimism.

Market Segmentation

Loading chart…

The Application segment of the Vaccines for Livestock Farming market taxonomy is critical to understanding demand dynamics. Swine farming dominates this category, accounting for 35% of the market, driven by the global demand for pork and the prevalence of diseases like swine flu. Cattle farming follows at 28%, fueled by the need for vaccines against bovine respiratory diseases and foot-and-mouth disease. Poultry farming contributes 22%, with a focus on vaccines for avian influenza and Newcastle disease. The remaining 15% includes sheep, goats, and other livestock. These segments collectively reflect the geographic and economic priorities of regions like Asia-Pacific and North America, where large-scale livestock operations are concentrated. Application-specific market shares highlight the role of animal husbandry practices and regulatory frameworks in shaping vaccine adoption.

The Types segment is divided into Live Attenuated Vaccines (45% market share) and Inactivated Vaccines (55% market share). Live attenuated vaccines are widely adopted for diseases like foot-and-mouth disease due to their cost-effectiveness and ability to induce strong immune responses. In contrast, inactivated vaccines dominate the market for safety-critical applications, such as in poultry, where residual virulence in live vaccines could pose risks. The balance between these types reflects trade-offs between efficacy, cost, and safety. Live vaccines remain popular in low- to mid-income regions, while inactivated vaccines cater to high-regulatory environments. This segmentation underscores technological advancements and the evolving preference for subunit and conjugate vaccines in niche applications, shaping the Vaccines for Livestock Farming market taxonomy.

Vaccines for Livestock Farming Segmentation Breakdown10 items

Application

Pig

Cattle

Sheep

Chicken and Duck

Other

Types

Live Attenuated Vaccines

Inactivated Vaccines

Other

Regional Insights

Loading chart…

The Vaccines for Livestock Farming market is dominated by North America, which holds the largest regional share, driven by advanced veterinary infrastructure, robust regulatory frameworks, and high adoption of preventive healthcare. Europe follows closely, supported by stringent animal welfare policies and investments in sustainable agriculture. The Asia Pacific region, however, is the fastest-growing market, fueled by rising livestock production, urbanization, and increasing demand for animal protein, particularly in China and India.

North America (value: 32) benefits from mature ecosystems, strong R&D investments, and public-private partnerships in livestock health. Europe (value: 28) emphasizes eco-friendly practices and cross-border collaborations, while Asia Pacific (value: 25) sees rapid growth due to expanding dairy and poultry sectors and government incentives for disease prevention. Latin America (value: 10) is progressing through improved access to vaccines and growing awareness, whereas the Middle East & Africa (value: 5) faces infrastructure challenges but gains traction via international aid and climate-resilient livestock programs.

Key drivers include demographics (urbanization in APAC), policy mandates (EU’s Green Deal), and ecosystem maturity (NA’s advanced cold chain). Investments in digital tools, such as IoT-based monitoring, are accelerating adoption globally. The regional forecast highlights APAC’s potential to surpass NA by 2030, positioning it as a strategic focus for stakeholders in the Vaccines for Livestock Farming market growth narrative.

Competitive Landscape

The Vaccines for Livestock Farming competitive landscape is moderately consolidated, with global players such as Merck and Zoetis coexisting alongside regional manufacturers like Ceva and Elanco. Market dynamics are shaped by pricing competition, regulatory compliance, and advancements in recombinant vaccine technologies. Regional players often leverage lower production costs and localized distribution networks, while global firms prioritize broad product portfolios and cross-border partnerships. Certification standards (e.g., USDA, EMA) and rapid regulatory approvals for novel vaccines remain critical differentiators, influencing market access and customer trust.

Strategic priorities include M&A activity to expand geographic footprints, joint ventures to reduce R&D costs, and targeted product launches for niche segments like aquaculture vaccines. However, margin pressures from raw material volatility and pricing erosion in commoditized markets constrain growth. Companies also face rising compliance costs due to evolving ESG and animal welfare regulations. Key differentiators include vertical integration for supply chain stability, proprietary adjuvant technologies, and tailored service models for smallholder farmers.

Merck: Innovation pipeline in recombinant vaccines

Zoetis: Regional expansion via acquisitions

Boehringer Ingelheim: Partnerships for poultry vaccine development

Ceva: Local manufacturing in emerging markets

Elanco: Product diversification for companion and farm animals

Virbac: Premium pricing for equine and aquatic vaccines

Key Vaccines for Livestock Farming Companies20 items

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

Chengdu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

Market Ecosystem

The Vaccines for Livestock Farming ecosystem spans upstream technology and raw material suppliers, midstream vaccine developers and manufacturers, and downstream distribution channels and end users. Value is generated through the integration of scientific innovation, regulatory compliance, and efficient supply chain logistics, with revenue captured across production, licensing, and service-based models.

Raw Material/Component Suppliers — Supply adjuvants, antigens, and packaging materials for vaccine formulation.

OEMs/Manufacturers — Produce vaccines using proprietary or licensed formulations.

Technology Providers — Develop platforms for vaccine innovation, including mRNA and recombinant methods.

Distributors/Channel Partners — Handle logistics and supply chain distribution to veterinary networks.

Service Providers/After-Sales — Offer technical support and monitoring for vaccine programs.

Regulators/Standards Bodies — Oversee compliance with safety and efficacy protocols.

End Users — Include commercial livestock farms and veterinary clinics administering vaccines.

Control points reside with regulators, who shape adoption through approval processes, and technology providers, whose platforms enable differentiation. Dependency risks include raw material availability, intellectual property licensing, and shifting regulatory standards. Switching costs are high for manufacturers tied to specialized technology, while interoperability is critical for downstream compliance and data integration.

Recent Industry Insights

The Vaccines for Livestock Farming industry trends highlight accelerated innovation driven by rising demand for food security and zoonotic disease prevention. Over the past 18 months, strategic partnerships such as Zoetis’ collaboration with a U.S.-based biotech firm to advance mRNA vaccine platforms have gained traction. Mergers & acquisitions activity surged, with Merck & Co. acquiring a niche poultry vaccine developer to bolster its portfolio in emerging markets. Product/technology launches include _oral vaccines for cattle_ and AI-powered diagnostics to enhance disease surveillance, while regulatory shifts in the EU and U.S. emphasize reduced antibiotic use, pushing producers toward preventive solutions. Enterprises are increasingly prioritizing sustainable vaccine production, aligning with consumer demand for ethically sourced animal products. Notably, a $120M funding round led by AgTech Ventures accelerated the development of heat-stable vaccines for low-resource regions, signaling a pivotal shift toward accessible, climate-resilient solutions.

Analyst Overview

The Vaccines for Livestock Farming market outlook remains robust, driven by rising global demand for animal protein, regulatory support, and advancements in disease prevention technologies. Market attractiveness is underscored by high-growth potential in emerging economies, where livestock production is expanding rapidly. Competitive intensity is moderate, with established players like Zoetis and Merck dominating, while biotech startups innovate in niche areas. The long-term outlook is optimistic, supported by increasing zoonotic disease concerns and food security needs, though regulatory delays pose risks. Innovation landscape is dynamic, with mRNA vaccines and digital monitoring tools gaining traction. Demand–supply balance shows rising demand, particularly in Asia-Pacific and Latin America, but production bottlenecks could strain supply chains. Key risk factors include high R&D costs, stringent approval processes, and climate-related disruptions. Strategic partnerships and diversified product portfolios are critical for sustaining growth.

12 items

1. Executive Summary

2. Vaccines for Livestock Farming Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Vaccines for Livestock Farming Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Vaccines for Livestock Farming Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Vaccines for Livestock Farming Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Vaccines for Livestock Farming Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Vaccines for Livestock Farming Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Vaccines for Livestock Farming Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Vaccines for Livestock Farming Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Vaccines for Livestock Farming Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Vaccines for Livestock Farming Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Vaccines for Livestock Farming Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Vaccines for Livestock Farming Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Vaccines for Livestock Farming Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Vaccines for Livestock Farming Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Vaccines for Livestock Farming Market Competition by Key Manufacturers

9.1. Global Vaccines for Livestock Farming Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Vaccines for Livestock Farming: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Zoetis

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boehringer Ingelheim

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ceva

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CAHIC

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. HVRI

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Ringpu Biology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Yebio

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. DHN

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. WINSUN

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Elanco

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Virbac

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Jinyu Bio-Technology

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Chengdu Tecbond

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. CAVAC

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Kyoto Biken Laboratories

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. FATRO

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Vaksindo

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Bio-Labs

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Avimex Animal Health

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Vaccines for Livestock Farming Market

Figure 4: Global Vaccines for Livestock Farming Market: Drivers

Figure 5: Global Vaccines for Livestock Farming Market: Challenges

Figure 6: Global Vaccines for Livestock Farming Market: Trends

Figure 7: Global Vaccines for Livestock Farming Market: Opportunity

Figure 8: Global Vaccines for Livestock Farming Market: Restraint

Figure 9: Global Vaccines for Livestock Farming Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Vaccines for Livestock Farming Market Value (USD Million) By Region

Figure 19: Global Vaccines for Livestock Farming Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Vaccines for Livestock Farming Market Value (USD Million) By Region

Figure 27: Global Vaccines for Livestock Farming Market Share (%) By: Regions (2032)

Figure 28: Global Vaccines for Livestock Farming Market Volume (K) By Region

Figure 29: Global Vaccines for Livestock Farming Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Vaccines for Livestock Farming Market Value (USD Million) By Region

Figure 37: Global Vaccines for Livestock Farming Market Share (%) By: Regions (2032)

Figure 38: Global Vaccines for Livestock Farming Market Volume (K) By Region

Figure 39: Global Vaccines for Livestock Farming Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Vaccines for Livestock Farming Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Vaccines for Livestock Farming Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Vaccines for Livestock Farming Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Vaccines for Livestock Farming Market Value (USD Million) By Region

Table 14: Global Vaccines for Livestock Farming Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Vaccines for Livestock Farming Market Volume (K) By Region

Table 31: Global Vaccines for Livestock Farming Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Vaccines for Livestock Farming Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Vaccines for Livestock Farming Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Vaccines for Livestock Farming Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: Zoetis Basic Information And Sales Area

Table 54: Zoetis. Products Portfolio

Table 55: Boehringer Ingelheim Basic Information And Sales Area

Table 56: Boehringer Ingelheim. Products Portfolio

Table 57: Ceva Basic Information And Sales Area

Table 58: Ceva. Products Portfolio

Table 59: CAHIC Basic Information And Sales Area

Table 60: CAHIC. Products Portfolio

Table 61: HVRI Basic Information And Sales Area

Table 62: HVRI. Products Portfolio

Table 63: Ringpu Biology Basic Information And Sales Area

Table 64: Ringpu Biology. Products Portfolio

Table 65: Yebio Basic Information And Sales Area

Table 66: Yebio. Products Portfolio

Table 67: DHN Basic Information And Sales Area

Table 68: DHN. Products Portfolio

Table 69: WINSUN Basic Information And Sales Area

Table 70: WINSUN. Products Portfolio

Table 71: Elanco Basic Information And Sales Area

Table 72: Elanco. Products Portfolio

Table 73: Virbac Basic Information And Sales Area

Table 74: Virbac. Products Portfolio

Table 75: Jinyu Bio-Technology Basic Information And Sales Area

Table 76: Jinyu Bio-Technology. Products Portfolio

Table 77: Chengdu Tecbond Basic Information And Sales Area

Table 78: Chengdu Tecbond. Products Portfolio

Table 79: CAVAC Basic Information And Sales Area

Table 80: CAVAC. Products Portfolio

Table 81: Kyoto Biken Laboratories Basic Information And Sales Area

Table 82: Kyoto Biken Laboratories. Products Portfolio

Table 83: FATRO Basic Information And Sales Area

Table 84: FATRO. Products Portfolio

Table 85: Vaksindo Basic Information And Sales Area

Table 86: Vaksindo. Products Portfolio

Table 87: Bio-Labs Basic Information And Sales Area

Table 88: Bio-Labs. Products Portfolio

Table 89: Avimex Animal Health Basic Information And Sales Area

Table 90: Avimex Animal Health. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Vaccines for Livestock Farming Market Value (USD Million) By Region

Table 100: Global Vaccines for Livestock Farming Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Vaccines for Livestock Farming Market Volume (K) By Region

Table 117: Global Vaccines for Livestock Farming Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Vaccines for Livestock Farming Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.81 billion
Revenue forecast in 2033	8.39 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Zoetis; Boehringer Ingelheim; Ceva; CAHIC; HVRI; Ringpu Biology; Yebio; DHN; WINSUN; Elanco; Virbac; Jinyu Bio-Technology; Chengdu Tecbond; CAVAC; Kyoto Biken Laboratories; FATRO; Vaksindo; Bio-Labs; Avimex Animal Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Fragmented veterinary infrastructure – Inadequate cold chain logistics and veterinary workforce shortages in low- and middle-income countries hinder vaccine distribution and adoption.

Opportunities2 items

Challenges2 items

Regulatory variability – Divergent approval processes across regions increase time-to-market complexity, particularly for multinational producers targeting emerging markets.

Market Segmentation

Loading chart…

Vaccines for Livestock Farming Segmentation Breakdown10 items

Application

Pig

Cattle

Sheep

Chicken and Duck

Other

Types

Live Attenuated Vaccines

Inactivated Vaccines

Other

Regional Insights

Loading chart…

Competitive Landscape

Merck: Innovation pipeline in recombinant vaccines

Zoetis: Regional expansion via acquisitions

Boehringer Ingelheim: Partnerships for poultry vaccine development

Ceva: Local manufacturing in emerging markets

Elanco: Product diversification for companion and farm animals

Virbac: Premium pricing for equine and aquatic vaccines

Key Vaccines for Livestock Farming Companies20 items

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

Chengdu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

Market Ecosystem

Raw Material/Component Suppliers — Supply adjuvants, antigens, and packaging materials for vaccine formulation.

OEMs/Manufacturers — Produce vaccines using proprietary or licensed formulations.

Technology Providers — Develop platforms for vaccine innovation, including mRNA and recombinant methods.

Distributors/Channel Partners — Handle logistics and supply chain distribution to veterinary networks.

Service Providers/After-Sales — Offer technical support and monitoring for vaccine programs.

Regulators/Standards Bodies — Oversee compliance with safety and efficacy protocols.

End Users — Include commercial livestock farms and veterinary clinics administering vaccines.

Recent Industry Insights

Analyst Overview

Table of Contents